WebMar-17-21 08:30AM. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2024 Results on March 25, 2024. PR Newswire +9.03%. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. WebJan 20, 2024 · Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.
My SAB Showing in a different state Local Search Forum
WebApr 11, 2024 · BIOLASE, Inc. (BIOL) CEO John Beaver On Q4 2024 Results - Earnings Call Transcript. SA Transcripts Thu, Mar. 17, 2024. WebApr 11, 2024 · A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. camping birthday party invitation
EX-101 INSTANCE DOCUMENT BIOLASE, INC Business …
WebBiolase hereby agrees to repurchase from Schein **** 182 MDs currently in Schein’s possession, free and clear of all liens and encumbrances. ... All documents shall be duly executed by authorized signatories and, when customary or necessary for filing or recordation, properly acknowledged. a. Biolase. Biolase shall ****, and less ****. WebBiolase Inc FDA Filings. This page includes the latest FDA filings for Biolase Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations. USA: NASDAQ: BIOL: DUNS 152165700: FDA Registration(s) Registration Number: 2027755: FEI Number: WebBiolase Inc. SEC filings breakout by MarketWatch. View the BIOL U.S. Securities and Exchange Commission reporting information. first watch fayetteville arkansas